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Background
Informed consent (IC) is regarded as a cornerstone of
ethical healthcare research and is a requirement for
most clinical research studies [1]. Guidelines suggest
that prospective clinical trial participants should under-
stand a basic amount of information about trials in
order to provide valid IC. However, poor participant
understanding of the research processes, a lack of
knowledge about the expectations and demands of trials
and insufficient support when faced with the decision
has been demonstrated across a range of clinical areas
[2,3]. As such, the existing approach to obtaining IC for
clinical trials is not optimal. Therefore, it is important
to investigate the effectiveness of the current consent
process to examine how well existing PILs conform to
empirically developed standards for promoting high
quality decisions. We propose that the process could be
improved by drawing on existing research in the fields
of decision making and decision support interventions.
Methods
Websites of Clinical Trial Units registered with the UK
Clinical Research Collaboration were screened to iden-
tify open access PILs from ongoing or recently com-
pleted randomised controlled trials (RCTs). A total of
60 PILs were identified and 20 were purposively
sampled, for analysis using the Informed Consent Eva-
luation instrument (ICEi). The ICEi was developed by
combining informed consent guidelines and the Interna-
tional Patient Decision Aid Standards (IPDAS), which
describe detailed recommendations about the content
and delivery of information to facilitate high quality
decisions for treatment or screening. Two independent
raters scored PILs according to the items presented in
the ICEi, any disagreement was resolved by a third rater.
Results
Variation existed amongst the PILs in terms of overall
scores and scores for specific items. Some aspects were
consistently poor across all PILs analysed, namely: pre-
senting probabilities; clarifying and expressing values;
and structured guidance in deliberation and
communication.
Conclusions
PILs could be improved to facilitate better quality deci-
sion making with regard to participation in an RCT.
Patients need to be better supported to make more
informed decisions about their clinical trial participation,
which are in line with their personal values and prefer-
ences. Better informed decisions about participation
may result in patients being retained throughout the
duration of the trial, as their decisions will be linked to
more realistic expectations and be more in line with
their personal values and preferences.
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